Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects.

CONCLUSION: Understanding genetic heterogeneity and involvement of neurotrophin biology in glaucoma could help to understand the complex pathophysiology of glaucoma. Identification of novel molecular targets will be critical for drug development and provide neuroprotection to the RGCs and optic nerve. PMID: 29676228 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29676228?dopt=Abstract

Source: Current Neuropharmacology - April 19, 2018 Category: Drugs & Pharmacology Authors: Chitranshi N, Dheer Y, Abbasi M, You Y, Graham SL, Gupta V Tags: Curr Neuropharmacol Source Type: research